AURA 2019 Third Australian report on antimicrobial use and resistance in human health
30 May 2019
Third Australian report on antimicrobial use and resistance in human health to increase the comprehensiveness of the picture of antimicrobial resistance (AMR), antimicrobial use and the appropriateness of antimicrobial prescribing in Australia, in hospitals, aged care, general practice and the community. AURA 2019 was released in May 2019 and builds on the earlier surveillance reports: AURA 2016 and AURA 2017.
Further reading: Australian Commission on Safety and Quality in Healthcare
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
